EndoPAT Device for Endothelial Dysfunction in ED

Recruiting now · Not applicable

Conditions studied: Erectile Dysfunction, Hypogonadism, Male, Endothelial Dysfunction

In brief

To assess endothelial dysfunction in young men (aged 30-50) with vasculogenic ED identified through penile Doppler ultrasound. To evaluate changes in endothelial function using EndoPAT before and 3-6 months after daily low-dose phosphodiesterase type 5 (PDE5) inhibitor therapy. To investigate endothelial function alterations in hypogonadal patients before and 3-6 months after initiating testosterone (T) therapy

Key facts

Study ID

NCT06720597

Run by

University of California, Irvine

People needed

120

Starts

2025-08-13

Expected to finish

2027-01-01

Last updated by the study team

2026-02-02

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Males 18 years old and above
• Diagnosed with erectile dysfunction or hypogonadism

You may not qualify if…

• Patients without the above criteria

Where it is running

• UCI Urology | Men's Health Center — Newport Beach, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.